These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8150017)

  • 21. The use of a systemic prime/mucosal boost strategy with an equine influenza ISCOM vaccine to induce protective immunity in horses.
    Crouch CF; Daly J; Henley W; Hannant D; Wilkins J; Francis MJ
    Vet Immunol Immunopathol; 2005 Dec; 108(3-4):345-55. PubMed ID: 16098611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence supporting the inclusion of strains from each of the two co-circulating lineages of H3N8 equine influenza virus in vaccines.
    Daly JM; Yates PJ; Newton JR; Park A; Henley W; Wood JL; Davis-Poynter N; Mumford JA
    Vaccine; 2004 Sep; 22(29-30):4101-9. PubMed ID: 15364463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Humoral response and antiviral cytokine expression following vaccination of thoroughbred weanlings--a blinded comparison of commercially available vaccines.
    Gildea S; Quinlivan M; Murphy BA; Cullinane A
    Vaccine; 2013 Oct; 31(45):5216-22. PubMed ID: 24021309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of equine influenza vaccines for protection against A/Equine/Jilin/89 (H3N8)--a new equine influenza virus.
    Webster RG; Thomas TL
    Vaccine; 1993; 11(10):987-93. PubMed ID: 8212831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of antigenic difference of equine influenza virus strains by challenge study in horses.
    Yamanaka T; Nemoto M; Bannai H; Tsujimura K; Kondo T; Matsumura T; Gildea S; Cullinane A
    Influenza Other Respir Viruses; 2016 Nov; 10(6):536-539. PubMed ID: 27465864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The first safe inactivated equine influenza vaccine formulation adjuvanted with ISCOM-Matrix that closes the immunity gap.
    Heldens JG; Pouwels HG; Derks CG; Van de Zande SM; Hoeijmakers MJ
    Vaccine; 2009 Sep; 27(40):5530-7. PubMed ID: 19607950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of different equine influenza vaccine products and other factors on equine influenza antibody levels in Thoroughbred racehorses.
    Ryan M; Gildea S; Walsh C; Cullinane A
    Equine Vet J; 2015 Nov; 47(6):662-6. PubMed ID: 25238593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Duration of immunity induced by an equine influenza and tetanus combination vaccine formulation adjuvanted with ISCOM-Matrix.
    Heldens JG; Pouwels HG; Derks CG; Van de Zande SM; Hoeijmakers MJ
    Vaccine; 2010 Oct; 28(43):6989-96. PubMed ID: 20728523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ISCOM-matrix-based equine influenza (EIV) vaccine stimulates cell-mediated immunity in the horse.
    Paillot R; Prowse L
    Vet Immunol Immunopathol; 2012 Jan; 145(1-2):516-21. PubMed ID: 22178272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and duration of immunity of a combined equine influenza and equine herpesvirus vaccine against challenge with an American-like equine influenza virus (A/equi-2/Kentucky/95).
    Heldens JG; Pouwels HG; van Loon AA
    Vet J; 2004 Mar; 167(2):150-7. PubMed ID: 14975389
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of a canarypox-vectored recombinant vaccine expressing the hemagglutinin gene of equine influenza H3N8 virus in the protection of ponies from viral challenge.
    Minke JM; Toulemonde CE; Coupier H; Guigal PM; Dinic S; Sindle T; Jessett D; Black L; Bublot M; Pardo MC; Audonnet JC
    Am J Vet Res; 2007 Feb; 68(2):213-9. PubMed ID: 17269889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Duration of circulating antibody and immunity following infection with equine influenza virus.
    Hannant D; Mumford JA; Jessett DM
    Vet Rec; 1988 Feb; 122(6):125-8. PubMed ID: 2835850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The evaluation of a nucleoprotein ELISA for the detection of equine influenza antibodies and the differentiation of infected from vaccinated horses (DIVA).
    Galvin P; Gildea S; Arkins S; Walsh C; Cullinane A
    Influenza Other Respir Viruses; 2013 Dec; 7 Suppl 4(Suppl 4):73-80. PubMed ID: 24224822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibody and IFN-gamma responses induced by a recombinant canarypox vaccine and challenge infection with equine influenza virus.
    Paillot R; Kydd JH; Sindle T; Hannant D; Edlund Toulemonde C; Audonnet JC; Minke JM; Daly JM
    Vet Immunol Immunopathol; 2006 Aug; 112(3-4):225-33. PubMed ID: 16621023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Accelerated vaccination schedule provides protective levels of antibody and complete herd immunity to equine influenza.
    El-Hage CM; Savage CJ; Minke JM; Ficorilli NP; Watson J; Gilkerson JR
    Equine Vet J; 2013 Mar; 45(2):235-9. PubMed ID: 22943193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of hamster and pony challenge models for evaluation of effect of antigenic drift on cross protection afforded by equine influenza vaccines.
    Daly JM; Yates RJ; Browse G; Swann Z; Newton JR; Jessett D; Davis-Poynter N; Mumford JA
    Equine Vet J; 2003 Jul; 35(5):458-62. PubMed ID: 12875323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunogenicity and protective efficacy of inactivated equine influenza (H3N8) virus vaccine in murine model.
    Pavulraj S; Virmani N; Bera BC; Joshi A; Anand T; Virmani M; Singh R; Singh RK; Tripathi BN
    Vet Microbiol; 2017 Oct; 210():188-196. PubMed ID: 29103691
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The relationship between single radial hemolysis, hemagglutination inhibition, and virus neutralization assays used to detect antibodies specific for equine influenza viruses.
    Morley PS; Hanson LK; Bogdan JR; Townsend HG; Appleton JA; Haines DM
    Vet Microbiol; 1995 Jun; 45(1):81-92. PubMed ID: 7653031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of the in situ immunological responses to vaccine adjuvants.
    Horohov DW; Dunham J; Liu C; Betancourt A; Stewart JC; Page AE; Chambers TM
    Vet Immunol Immunopathol; 2015 Mar; 164(1-2):24-9. PubMed ID: 25619587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Equine influenza vaccine performance: still learning lessons from the field.
    Newton JR
    Vet J; 2001 Mar; 161(2):107-9. PubMed ID: 11243681
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.